We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This table sets out the 2021 to 2022 data for the local diabetic eye screening (DES) services in England.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Guidance for the NHS diabetic eye screening (DES) programme.
Batch recall alert for human eye gels that may be prescribed by vets and used under the cascade.
This document sets out the programme specific operating model for quality assurance of the NHS diabetic eye screening (DES) programme.
Contains the retinal image grading criteria for NHS Diabetic Eye Screening (DES) Programme and information about how to record results.
This table sets out the 2019 to 2020 data for the local diabetic eye screening (DES) services in England.
Onchocerciasis is an eye and skin disease that causes severe discomfort and can lead to permanent blindness.
Guidance on the use of mydriatic eye drops in the NHS diabetic eye screening (DES) programme.
Advice on making reasonable adjustments to eye care services so they are accessible to people with learning disabilities.
Leaflet explaining how diabetic eye screening (DES) works, to help healthcare professionals discuss screening and results with their patients.
This table sets out the 2020 to 2021 data for the local diabetic eye screening (DES) services in England.
This document contains a synopsis of causation occurring in eye injuries.
Batches of Legency Remedies Pvt Ltd irrigation, inhalation and eye wash saline products manufactured between April and November 2023 are being recalled due to potential microbiological contamination.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.